KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Capital Expenditures (2018 - 2026)

Moderna (MRNA) has disclosed Capital Expenditures for 9 consecutive years, with $35.0 million as the latest value for Q1 2026.

  • For Q1 2026, Capital Expenditures fell 30.0% year-over-year to $35.0 million; the TTM value through Mar 2026 reached $177.0 million, down 82.48%, while the annual FY2025 figure was $192.0 million, 81.73% down from the prior year.
  • Capital Expenditures hit $35.0 million in Q1 2026 for Moderna, down from $150.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $559.0 million in Q4 2023 and bottomed at -$199.0 million in Q3 2023.
  • Average Capital Expenditures over 5 years is $140.3 million, with a median of $91.0 million recorded in 2024.
  • Year-over-year, Capital Expenditures plummeted 14000.0% in 2022 and then surged 1500.0% in 2025.
  • Moderna's Capital Expenditures stood at $320.0 million in 2022, then soared by 74.69% to $559.0 million in 2023, then dropped by 6.62% to $522.0 million in 2024, then plummeted by 71.26% to $150.0 million in 2025, then crashed by 76.67% to $35.0 million in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $35.0 million, $150.0 million, and -$78.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.